Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACYW Vaccine in Healthy Infants and Toddlers
NCT03630705Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2018
- Primary completion
- Feb 2022
- Countries
- 2
01
Overview
A Phase 3 trial of meningococcal polysaccharide A, C, W and Y vaccine, tetanus toxoid conjugate in meningococcal infection, sponsored by Sanofi. Started Oct 2018; status: completed.
02
Drugs
meningococcal polysaccharide A, C, W and Y vaccine, tetanus toxoid conjugate
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT03630705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03630705.